Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9417-9426

  Chen, Chun Ming ^a   You, Li Ru ^a   Hwang, Lih Hwa ^b   Lee, Yan Hwa Wu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; CYCLOHEXIMIDE; GAMMA INTERFERON; LYMPHOTOXIN;

ARTICLE; BINDING AFFINITY; CYTOLYSIS; GENE ISOLATION; HEPATITIS C; HEPATITIS C VIRUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 0030729202     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9417-9426.1997     Document Type: Article

References (92)

1. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Network 7:93-124.
2. Agnello, V., R. T. Chung, and L. M. Kaplan. 1992. A role for hepatitis C virus infection in type II cryoglobulinemia. N. Engl. J. Med. 327:1490-1495.
3. Almasio, P., G. Provenzano, M. Scimemi, G. Cascio. A. Craxi, and L. Pagliaro. 1992. Hepatitis C virus and Sjogren's syndrome. Lancet 339:989-990.
4. Baens, M., M. Chaffanet, J. J. Cassiman, H. Den Berghe, and P. Marynen. 1993. Construction and evaluation of a HNcDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16:214-218.
5. Baeuerle, P. A., and D. Baltimore. 1996. NF-KB: ten years after. Cell 87:13-20.
6. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated protein. Oncogene 12:1-9.
7. Barba, G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura, and C. Brechot. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA 94:1200-1205.
8. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1993. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67:3835-3844.
9. Battegay, M., J. Fikes, A. M. DiBisceglie, P. A. Wentworth, A. Sette, E. Celis, W.-M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462-2470.
10. Berg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784.
11. Beutler, B., and C. van Huffel. 1994. Unraveling functions in the TNF ligand and receptor families. Science 264:667-668.
12. Boldin, M. P., I. L. Mett, E. E. Varfolomeev, I. Chumakov, Y. Shemer-Avin, J. H. Camonis, and D. Wallach. 1995. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/Apol prompts signaling for TNF and Fas/Apol effects. J. Biol. Chem. 270:387-391.
13. Browning, J. L., K. Miatkowski, and D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier. 1996. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins α and β. J. Biol. Chem. 271:8616-8626.
14. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867-878.
15. Bruix, J., J. M. Barrera, X. Calvet, G. Ercilla, J. Costa, J. M. Sanchez-Tapias, M. Ventura, M. Vall, M. Bruguera, C. Bru, R. Castillo, and J. Rhodes. 1989. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet ii:1004-1006.
16. Cerny, A., J. G. McHutchinson, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521-530.
17. Chen, M. J., B. Holskin, J. Strickler, J. Gorniak, M. A. Clark, P. J. Johnson, M. Mitcho, and D. Shalloway. 1987. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature 330:581-583.
18. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacte with the death domain of Fas and initiates apoptosis. Cell 81:505-512.
19. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
20. Colombo, M., G. Kuo, Q.-L. Choo, M. F. Donato, E. Del Ninno, M. Tonnasini, N. Dioguardi, and M. Houghton. 1989. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet ii:1006-1008.
21. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707-710.
22. Debbas, M., and E. Wold. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:545-554.
23. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
24. Dimitrov, T., P. Krajcsi, T. W. Henniston, A. E. Tollefson, M. Hannink, and W. S. M. Wold. 1997. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phosphlipase A2 to membranes. J. Virol. 71:2830-2837.
25. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-4200.
26. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. F. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
27. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
28. Gooding, L. R., L. Aquino, P. J. Duerksen-Hugghes, D. Day, T. M. Hurton, S. P. Yeu, and W. S. M. Wold. 1991. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J. Virol. 65:3083-3094.
29. Gooding, L. R., L. W. Elmore, A. E. Tollefson, L. Aquino, H. P. Duerksen, T. M. Horton, and W. S. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
30. Goring, D. R., J. Rossant, S. Clapoff, M. L. Breitnal, and L.-C. Tsui. 1989. In situ detection of β-galactosidase in lenses of transgenic mice with a γ-crystallin/lacZ gene. Science 235:456-458.
31. Graham, F., and A. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:455-467.
32. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832-2843.
33. Gruss, H.-J., and S. K. Dower. 1995. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404.
34. Haddad, J., P. Deny, C. Munz-Gotheil, J. C. Ambrosini, J. C. Trinchet, D. Paterson, F. Mal, P. Callard, and M. Beaugrand. 1992. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323.
35. Heller, R. A., and M. Kronk. 1994. Tumor necrosis factor-mediated signaling pathways. J. Cell Biol. 126:5-9.
36. Hijikata, M., H. Mizushima, T. Akagi, S. Mon, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:4665-4675.
37. Hiramatsu, N., N. Hayashi, K. Katayama, K. Mochizuki, Y. Kawanishi, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359.
38. Hsieh, C.-L., B.-F. Chen, C.-C. Wang, H.-H. Liu, D.-S. Chen, and L.-H. Hwang. 1995. Improved gene expression by a modified bicistronic retroviral vector. Biochem. Biophys. Res. Commun. 214:910-917.
39. Hsu, H., J. Huang, H.-B. Shu, V. Baichwal, and D. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387-397.
40. Hsu, H., H.-B. Shu, M.-G. Pan, and D. Goeddel. 1996 TRADD-TRAF2 and TRADD-FADD interaction define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
41. Hsu, H., J. Xiong, and D. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504.
42. Johnson, R. J., D. R. Gretch, H. Yamabe, J. Hart, C. E. Bacchi, P. Hartwell, W. G. Couser, L. Corey, M. H. Wener, C. E. Alpers, and R. Willson. 1993. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 328:465-470.
43. Kew, M. C., M. Houghton, Q.-L. Cboo, and G. Kuo. 1990. Hepatitis C virus antibodies in Southern Africa blacks with hepatocellular carcinoma. Lancet 335:873-874.
44. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of Fas ligand in the development of hepatitis. Nat. Med. 3:409-413.
45. Koziel, M. J., D. Dudley, N. Afdhal, Q. L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
46. Krajcsi, P., T. Dimitrov, T. W. Hermiston, A. E. Tollefson, T. S. Ranheim, S. B. Vande Pol, A. H. Stephenson, and W. S. M. Wold. 1996. The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachiconic acid. J. Virol. 70:4904-4913.
47. Kuo, G., Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Shuster, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
48. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
49. Lin, C., B. D. Lindenbach, B. M. Pragai, D. W. McCourt, and C. M. Rice. 1994. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termim. J. Virol. 68:5063-5073.
50. Liu, H.-S., H. Scrable, D. B. Villaret, M. A. Lieberman, and P. J. Strambrook. 1992 Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res. 52:983-989.
51. Liu, Z.-G., H. Hsu, D. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
52. Lo, S.-Y., F. Masiarz, S. B. Hwang, M. M. C. Lai, and J-H. Ou. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
53. Lo, S.-Y., M. J. Selby, and J-H. Ou. 1996. Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 70:5177-5182.
54. Lunel, F. 1994. Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology 107:1550-1555.
55. Mackay, F., G. R. Majeau, P. S. Hochman, and J. L. Browning. 1996. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J. Biol. Chem. 271:24934-24938.
56. Matsumoto, M., T.-Y. Hsieh, N. Zhu, T. Vanarsdale, S. B. Hwang, K.-S. Jeng, A. E. Gorbalenya, S.-Y. Lo, J.-H. Ou, C. F. Ware, and M. M. Lai. 1997. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71:1301-1309.
57. Miller, J. H. 1977. Experiments in molecular genetics, 3rd ed., p. 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
58. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsda, C. F. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
59. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355-365.
60. Nakano, H., H. Oshima, W. Chung, L. Williams-Abott, C. F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661-14664.
61. Odermatt, B., M. Eppler, T. P. Leist, H. Hengartner, and R. M. Zinkernagel. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl. Acad. Sci. USA 88:8252-8256.
62. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monoatogenes infection. Cell 73:457-467.
63. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:209-220.
64. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:4438-4443.
65. Ray, R. B., K. Meyer, and R. Ray. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176-182.
66. Rehermann, B., K.-M. Chang, J. McHutchison, R. Kokka, M. Houghton, C. M. Rice, and F. V. Chisari. 1996. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092-7102.
67. Rice, C. M., and C. M. Walker. 1995. Hepatitis C virus-like T lymphocyte responses. Curr. Opin. Immunol. 7:532-538.
68. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumor necrosis factor receptors are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
69. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated action of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427.
70. Rothe, M., S. C. Wong, W. J. Henzel, and D. V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692.
71. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229: 68-76.
72. Sabbatini, P. S. K. Chiou, L. Rao, and E. White. 1995. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060-1070.
73. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, S. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547-6549.
74. Sakamuro, D., T. Furukawa, and T. Takegami. 1995. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol. 69:3893-3896.
75. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
76. Santollini, E., G. Migliaccio, and N. L. Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68: 3631-3641.
77. Selby, M. J., Q.-L. Choo, K. Berger, G. Kuo, E. Glazer, M. Eckart, C. Lee, D. Chien, C. Kuo, and M. Houghton. 1993. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J. Gen. Virol. 74:1103-1113.
78. Shen, Y., and T. E. Shenk. 1995. Viruses and apoptosis. Curr. Opin. Genet. Dev. 5:105-111.
79. Shih, C.-M.; C-M. Chen, S-Y. Chen, and Y-H. W. Lee. 1995. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69:1160-1171.
80. Shih, C.-M., S. J. Lo, T. Miyamura, S-Y. Chen, and Y.-H. W. Lee. 1993. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:5823-5832.
81. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959-962.
82. Song, H. Y., J. D. Dunbar, and D. B. Donner. 1994. Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. J. Biol. Chem. 269:22492-22495.
83. Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746.
84. Tewari, M., and V. M. Dixit. 1996. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:39-44.
85. Thanos, D., and T Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
86. Tomei, L., C. Failla, E. Santolini, R. D. Francesco, and N. L. Monica. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:4017-4026.
87. Tran, A., J.-F. Quaranta, S. Benzaken, V. Thiers, H. T. Chau, P. Hastier, D. Regnier G. Dreyfus, C. Pradier, J.-L. Sadoul, X. Hebutern, and P. Rampal. 1992. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253-257.
88. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
89. Vandenabeele, P., W. Declereq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5:392-399.
90. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microbiol. Immunol. 198:175-218.
91. White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol. Cell. Biol. 12:2570-2580.
92. Wong, G. H. W., and D. V. Goeddel. 1994. Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152:1751-1755.